Detail akcie Itonis online

Business Summary: Itonis Inc. operates as a holding company. The Company’s Pharmaceuticals division to produce and market over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The Company has launched the retails sale of the Emesyl nausea relief product. The Company has identified the market for its Emesyl product line as the general public who suffers from nausea. Emesyl has been available for purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com. Its subsidiaries include Itonis Holdings, Inc., Itonis Pharmaceuticals, and Paramount Discoveries, Inc.
Financial Summary: BRIEF: For the fiscal year ended 30 November 2014, ITonis Inc revenues was not reported. Net loss increased from $193K to $1.2M. Higher net loss reflects Loss on Investment in Paramount increase from $0K to $608K (expense), Executive compensation increase from $173K to $488K (expense), General and administrative increase from $18K to $57K (expense).